Ultra High Frequency Electrocardiogram (UHF-ECG)
DeviceElectrocardiograms used on participants scheduled to undergo pacemaker implantation for bradycardia and/or heart failure.
Other names: Standard 12 lead Electrocardiogram (ECG)
NCT Number: NCT06641362
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Fakultní nemocnice Brno, Brno, Czechia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electrocardiograms used on participants scheduled to undergo pacemaker implantation for bradycardia and/or heart failure.
Other names: Standard 12 lead Electrocardiogram (ECG)
Time frame: Pre-procedure
Positive and negative predictive agreement between standard 12-lead ECG and UHF-ECG in discrimination of ventricular synchrony versus dyssynchrony with one recording per participant taken pre-procedure as evaluated by the core laboratory.
Time frame: Pre-procedure
Predictive agreement of ventricular dyssynchrony and sidedness on the pre-procedure 12-lead ECG compared of UHF-ECG in participants with identified ventricular dyssynchrony.
Contact information is provided by the study sponsor or research team.
VDI Technologies
Industry
Pivotal Clinical Study of VDI's Ultra-High Frequency Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED): THE SYNC Study
Acronym: SYNC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00284830
Arrhythmia, Sinus, Arrhythmias, Cardiac
Phoenix, Arizona, United States
View Trial DetailsNCT07393009
Arrhythmias, Cardiac, Bradycardia
Adelaide, Australia
View Trial DetailsNCT00271180
Arrhythmia, Arrhythmias, Cardiac
Birmingham, Alabama, United States
View Trial DetailsNCT07563153
Arrhythmias, Cardiac, Bradycardia
Seoul, South Korea
View Trial Details